161.
Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice
by Chen, Xiuping
Journal of vascular research, 2016-06, Vol.52 (6), p.372-382
162.
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
by Stephens, N.G
The Lancet (British edition), 1996, Vol.347 (9004), p.781-786
163.
High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery: Association With Reduced CCAAT/Enhancer Binding Protein Homologous Protein and Total Pl...
by Zulli, Anthony
Hypertension (Dallas, Tex. 1979), 2009-06, Vol.53 (6), p.1017-1022
164.
The use of medications in the secondary prevention of coronary artery disease in the Asian region
by Dalal, Jamshed
Current medical research and opinion, 2015-03, Vol.31 (3), p.423-433
165.
Effect of Gender, Caregiver, on Cholesterol Control and Statin Use for Secondary Prevention Among Hospitalized Patients With Coronary Heart Disease
by Hammond, Gmerice, MD
The American journal of cardiology, 2012, Vol.110 (11), p.1613-1618
166.
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the Meantime, Some Challenges and Recommendations
by Martin, Seth S., MD
The American journal of cardiology, 2012, Vol.110 (2), p.307-313
167.
Effect of a Telephone-Delivered Coronary Heart Disease Secondary Prevention Program (ProActive Heart) on Quality of Life and Health Behaviours: Primary Outcomes of a Randomised Con...
by Hawkes, Anna L
International journal of behavioral medicine, 2012-07-18, Vol.20 (3), p.413-424
168.
Management of Kawasaki disease: corticosteroids revisited
by Son, Mary Beth F
The Lancet (British edition), 2012, Vol.379 (9826), p.1571-1572
169.
Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive cor...
by Ladapo, Joseph A
Menopause (New York, N.Y.), 2015-11, Vol.22 (11), p.1224-1230
170.
Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (RE...
by Nissen, Steven E
The American journal of cardiology, 2005, Vol.96 (5), p.61-68
171.
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUR...
by Bertrand, Michel E., MD, FRCP, FESC, FACC
The American heart journal, 2010, Vol.159 (5), p.795-802
172.
Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis
by Sanchez, Daniel R., MD
The American journal of cardiology, 2011, Vol.107 (1), p.41-46
173.
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial
by VERMEULEN, E. G. J
The Lancet (British edition), 2000, Vol.355 (9203), p.517-522
174.
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
by van der Valk, M
AIDS (London), 2001, Vol.15 (18), p.2407-2414
175.
Effects of bazedoxifene alone and with conjugated equine estrogens on coronary and peripheral artery atherosclerosis in postmenopausal monkeys
by Clarkson, Thomas B.
Menopause (New York, N.Y.), 2013-03, Vol.20 (3), p.274-281
176.
The feasibility and accuracy of evaluating lipid management performance metrics using an electronic health record
by Danford, Christopher P., MD
The American heart journal, 2013, Vol.166 (4), p.701-708
177.
Implications of New Hypertension Guidelines in the United States
by Bertoia, Monica L
Hypertension (Dallas, Tex. 1979), 2011-09, Vol.58 (3), p.361-366
178.
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
by Ishibashi, Minako
Hypertension (Dallas, Tex. 1979), 2002-11, Vol.40 (5), p.687-693
179.
Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COU...
by Maron, David J., MD
The American journal of cardiology, 2013, Vol.111 (11), p.1557-1562
180.
Moderate Alcohol Consumption and the Risk of Mortality
by Fuller, Theodore D
Demography, 2011-08-01, Vol.48 (3), p.1105-1125
